Variable | n | % |
---|---|---|
Number of patients | 22 | Â |
Age at time of resection (years) | 48 (33–64) |  |
Sex | Â | Â |
 Male | 14 | 64 |
 Female | 8 | 36 |
Prior systemic treatment | Â | Â |
 None | 4 | 18 |
 IL-2 | 11 | 50 |
 IFN alpha 2b | 10 | 45 |
 Adoptive cell transfer | 1 | 4.5 |
 Chemotherapy | 3 | 14 |
 Biochemotherapy* | 1 | 4.5 |
 Vaccine | 3 | 14 |
 Anti-CTLA-4 antibody | 2 | 9 |
 Tyrosine kinase inhibitor | 1 | 4.5 |
 BRAF inhibitor | 1 | 4.5 |
Indication for metastasectomy | Â | Â |
 TIL | 20 | 91 |
 TIL/NED | 2 | 9 |
 Diagnosis | 0 | 0 |